Background A better description of the clinical and laboratory manifestations of fatal patients with dengue hemorrhagic fever (DHF) is important in alerting clinicians of severe dengue and improving management. Methods and Findings Of 309 adults with DHF, 10 fatal patients and 299 survivors (controls) were retrospectively analyzed. Regarding causes of fatality, massive gastrointestinal (GI) bleeding was found in 4 patients, dengue shock syndrome (DSS) alone in 2; DSS/subarachnoid hemorrhage, Klebsiella pneumoniae meningitis/bacteremia, ventilator associated pneumonia, and massive GI bleeding/Enterococcus faecalis bacteremia each in one. Fatal patients were found to have significantly higher frequencies of early altered consciousness (≤24 h after hospitalization), hypothermia, GI bleeding/massive GI bleeding, DSS, concurrent bacteremia with/without shock, pulmonary edema, renal/hepatic failure, and subarachnoid hemorrhage. Among those experienced early altered consciousness, massive GI bleeding alone/with uremia/with E. faecalis bacteremia, and K. pneumoniae meningitis/bacteremia were each found in one patient. Significantly higher proportion of bandemia from initial (arrival) laboratory data in fatal patients as compared to controls, and higher proportion of pre-fatal leukocytosis and lower pre-fatal platelet count as compared to initial laboratory data of fatal patients were found. Massive GI bleeding (33.3%) and bacteremia (25%) were the major causes of pre-fatal leukocytosis in the deceased patients; 33.3% of the patients with pre-fatal profound thrombocytopenia (<20000/μL), and 50% of the patients with pre-fatal prothrombin time (PT) prolongation experienced massive GI bleeding. Conclusions Our report highlights causes of fatality other than DSS in patients with severe dengue, and suggested hypothermia, leukocytosis and bandemia may be warning signs of severe dengue. Clinicians should be alert to the potential development of massive GI bleeding, particularly in patients with early altered consciousness, profound thrombocytopenia, prolonged PT and/or leukocytosis. Antibiotic(s) should be empirically used for patients at risk for bacteremia until it is proven otherwise, especially in those with early altered consciousness and leukocytosis.
References
[1]
Guzman MG, Kouri G (2001) Dengue: an update. Lancet Infect Dis 2: 33–42. doi: 10.1016/S1473-3099(01)00171-2
[2]
Sumarmo , Wulur H, Jahja E, Gubler DJ, Suharyono W, et al. (1983) Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull WHO 61: 693–701.
[3]
Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S (1993) Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 92: 111–115.
[4]
Nimmannitya S (1994) Dengue fever/dengue haemorrhagic fever: case management. Trop Med (Nagasaki) 36: 249–256.
[5]
Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, et al. (1998) Dengue and dengue haemorrhagic fever. Lancet 352: 971–977. doi: 10.1016/S0140-6736(97)12483-7
[6]
Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, et al. (1998) Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 4: 89–92. doi: 10.3201/eid0401.980111
[7]
Halstead SB (1999) Is there an inapparent dengue explosion? Lancet 353: 1100–1101. doi: 10.1016/S0140-6736(05)76460-6
[8]
Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, et al. (1999) Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 3: 130–135. doi: 10.1016/S1201-9712(99)90033-4
[9]
Ranjit S, Kissoon N, Jayakumar I (2005) Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatric Crit Med 6: 412–419. doi: 10.1097/01.pcc.0000163676.75693.bf
[10]
Kamath SR, Ranjit S (2006) Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. Indian J Pediatr 73: 889–895. doi: 10.1007/BF02859281
[11]
José G, Rigau-Pérez , Laufer MiriamK (2006) Dengue-related deaths in Puerto Rico, 1992–1996: diagnosis and clinical alarm signals. Clin Infect Dis 42: 1241–1246. doi: 10.1086/501355
[12]
Ong A, Sandar M, Chen MI, Sin LY (2007) Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis 11: 263–267. doi: 10.1016/j.ijid.2006.02.012
[13]
Nguyen TH, Nguyen TL, Lei HY, Lin YS, Le BL, et al. (2006) Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. Am J Trop Med Hyg 74: 684–691.
[14]
Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, et al. (2006) The WHO dengue classification and case definitions: time for a reassessment. Lancet 368: 170–173. doi: 10.1016/S0140-6736(06)69006-5
[15]
Liu JW, Khor BS, Lee CH, Lee IK, Chen RF, et al. (2003) Dengue haemorrhagic fever in Taiwan. Dengue Bull 27: 19–23.
[16]
Lee IK, Liu JW, Yang KD (2009) Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg 80: 651–655.
[17]
World Health Organization (1997) Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization.
[18]
World Health Organization (2009) Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization.
[19]
Cornbleet PJ (2002) Clinical utility of the band count. Clin Lab Med 22: 101–36. doi: 10.1016/S0272-2712(03)00069-6
[20]
Natth Bhamarapravati N, Boonyapaknavik V, Nimsomburana P (1966) Pathology of Thai haemorrhagic fever: an autopsy study. Bull World Health Organ 25: 47–48.
[21]
Tsai CJ, Kuo CH, Chen PC, Changcheng CS (1991) Upper gastrointestinal bleeding in dengue fever. Am J Gastroenterol 86: 33–35.
[22]
Basílio-de-Oliveira CA, Aguiar GR, Baldanza MS, Barth OM, Eyer-Silva WA, et al. (2005) Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro, Brazil. Braz J Infect Dis 9: 341–347. doi: /S1413-86702005000400012
[23]
American Society of Health-System Pharmacists Commission on Therapeutics (1999) ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 56: 347–379.
[24]
Lee IK, Liu JW, Yang KD (2005) Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg 72: 221–226.
[25]
Vejchapipat P, Theamboonlers A, Chongsrisawat V, Poovorawan Y (2006) An evidence of intestinal mucosal injury in dengue infection. Southeast Asian J Trop Med Public Health 37: 79–82.
Sava IG, Heikens E, Huebner J (2010) Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 16: 533–540. doi: 10.1111/j.1469-0691.2010.03213.x
[28]
Parkash O, Almas A, Jafri SM, Hamid S, Akhtar J, et al. (2010) Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol 10: 43. doi: 10.1186/1471-230X-10-43
[29]
Viswanathan S, Iqbal N, Anemon PP, Kumar GS (2010) Fatal fulminant hepatic failure in a diabetic with primary dengue. J Trop Med 2010: Article ID 413561. doi: 10.1155/2010/413561
